211 related articles for article (PubMed ID: 21692479)
1. Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).
Steffen JD; Coyle DL; Damodaran K; Beroza P; Jacobson MK
J Med Chem; 2011 Aug; 54(15):5403-13. PubMed ID: 21692479
[TBL] [Abstract][Full Text] [Related]
2. PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment.
Johnson S; Karpova Y; Guo D; Ghatak A; Markov DA; Tulin AV
BMC Cancer; 2022 May; 22(1):557. PubMed ID: 35585513
[TBL] [Abstract][Full Text] [Related]
3. Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer.
Martincuks A; Zhang C; Austria T; Li YJ; Huang R; Lugo Santiago N; Kohut A; Zhao Q; Borrero RM; Shen B; Cristea M; Wang EW; Song M; Rodriguez-Rodriguez L; Yu H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580335
[TBL] [Abstract][Full Text] [Related]
4. DePARylation is critical for S phase progression and cell survival.
Nie L; Wang C; Huang M; Liu X; Feng X; Tang M; Li S; Hang Q; Teng H; Shen X; Ma L; Gan B; Chen J
Elife; 2024 Apr; 12():. PubMed ID: 38578205
[TBL] [Abstract][Full Text] [Related]
5. Monitoring Poly(ADP-ribosyl)glycohydrolase Activity with a Continuous Fluorescent Substrate.
Drown BS; Shirai T; Rack JGM; Ahel I; Hergenrother PJ
Cell Chem Biol; 2018 Dec; 25(12):1562-1570.e19. PubMed ID: 30318463
[TBL] [Abstract][Full Text] [Related]
6. DePARylation is critical for S phase progression and cell survival.
Nie L; Wang C; Huang M; Liu X; Feng X; Tang M; Li S; Hang Q; Teng H; Shen X; Ma L; Gan B; Chen J
bioRxiv; 2024 Feb; ():. PubMed ID: 37577639
[TBL] [Abstract][Full Text] [Related]
7. PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.
Andronikou C; Burdova K; Dibitetto D; Lieftink C; Malzer E; Kuiken HJ; Gogola E; Ray Chaudhuri A; Beijersbergen RL; Hanzlikova H; Jonkers J; Rottenberg S
EMBO J; 2024 Mar; 43(6):1015-1042. PubMed ID: 38360994
[TBL] [Abstract][Full Text] [Related]
8. CHK1 inhibitor induced PARylation by targeting PARG causes excessive replication and metabolic stress and overcomes chemoresistance in ovarian cancer.
Acharya G; Mani C; Sah N; Saamarthy K; Young R; Reedy MB; Sobol RW; Palle K
Cell Death Discov; 2024 Jun; 10(1):278. PubMed ID: 38862485
[TBL] [Abstract][Full Text] [Related]
9. Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models.
Coulson-Gilmer C; Morgan RD; Nelson L; Barnes BM; Tighe A; Wardenaar R; Spierings DCJ; Schlecht H; Burghel GJ; Foijer F; Desai S; McGrail JC; Taylor SS
J Exp Clin Cancer Res; 2021 Oct; 40(1):323. PubMed ID: 34656146
[TBL] [Abstract][Full Text] [Related]
10. Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence.
Fabbrizi MR; Nickson CM; Hughes JR; Robinson EA; Vaidya K; Rubbi CP; Kacperek A; Bryant HE; Helleday T; Parsons JL
Cell Death Dis; 2024 Feb; 15(2):150. PubMed ID: 38368415
[TBL] [Abstract][Full Text] [Related]
11. Live Cell Detection of Poly(ADP-Ribose) for Use in Genetic and Genotoxic Compound Screens.
Koczor CA; Haider AJ; Saville KM; Li J; Andrews JF; Beiser AV; Sobol RW
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954352
[TBL] [Abstract][Full Text] [Related]
12. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.
Qin W; Chung AC; Huang XR; Meng XM; Hui DS; Yu CM; Sung JJ; Lan HY
J Am Soc Nephrol; 2011 Aug; 22(8):1462-74. PubMed ID: 21784902
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide.
Wu CC; Li TK; Farh L; Lin LY; Lin TS; Yu YJ; Yen TJ; Chiang CW; Chan NL
Science; 2011 Jul; 333(6041):459-62. PubMed ID: 21778401
[TBL] [Abstract][Full Text] [Related]
14. Subcellular targeting of Salmonella virulence proteins by host-mediated S-palmitoylation.
Hicks SW; Charron G; Hang HC; Galán JE
Cell Host Microbe; 2011 Jul; 10(1):9-20. PubMed ID: 21767808
[TBL] [Abstract][Full Text] [Related]
15. A majority of the cancer/testis antigens are intrinsically disordered proteins.
Rajagopalan K; Mooney SM; Parekh N; Getzenberg RH; Kulkarni P
J Cell Biochem; 2011 Nov; 112(11):3256-67. PubMed ID: 21748782
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of γ-tubulin complex protein GCP4 provides insight into microtubule nucleation.
Guillet V; Knibiehler M; Gregory-Pauron L; Remy MH; Chemin C; Raynaud-Messina B; Bon C; Kollman JM; Agard DA; Merdes A; Mourey L
Nat Struct Mol Biol; 2011 Jul; 18(8):915-9. PubMed ID: 21725292
[TBL] [Abstract][Full Text] [Related]
17. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair.
Cortellino S; Xu J; Sannai M; Moore R; Caretti E; Cigliano A; Le Coz M; Devarajan K; Wessels A; Soprano D; Abramowitz LK; Bartolomei MS; Rambow F; Bassi MR; Bruno T; Fanciulli M; Renner C; Klein-Szanto AJ; Matsumoto Y; Kobi D; Davidson I; Alberti C; Larue L; Bellacosa A
Cell; 2011 Jul; 146(1):67-79. PubMed ID: 21722948
[TBL] [Abstract][Full Text] [Related]
18. A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism.
Marschner K; Kollmann K; Schweizer M; Braulke T; Pohl S
Science; 2011 Jul; 333(6038):87-90. PubMed ID: 21719679
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin.
Isogai S; Morimoto D; Arita K; Unzai S; Tenno T; Hasegawa J; Sou YS; Komatsu M; Tanaka K; Shirakawa M; Tochio H
J Biol Chem; 2011 Sep; 286(36):31864-74. PubMed ID: 21715324
[TBL] [Abstract][Full Text] [Related]
20. Quantitative single cell monitoring of protein synthesis at subcellular resolution using fluorescently labeled tRNA.
Barhoom S; Kaur J; Cooperman BS; Smorodinsky NI; Smilansky Z; Ehrlich M; Elroy-Stein O
Nucleic Acids Res; 2011 Oct; 39(19):e129. PubMed ID: 21795382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
